AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)

RecruitingPhase 3Ages 18 Years - anyAllGiulia Manzini
💬

In plain words

What the trial is, and whether it could suit you

Bile leakage (BL) is the most frequent complication after liver resection. This study is to investigate the role of intraoperative administration of SMOFlipid 20% (fat emulsion which allows intraoperative identification of open bile ducts at the liver resection surface when it is administered retrograde through the cystic duct) in terms of prevention of postoperative BL within 30 days after surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who will receive an anatomical resection of two or more liver segments for any reason with simultaneous cholecystectomy in elective Setting * Patients who will receive an anatomical resection of two or more liver segments for any reason which already had a cholecystectomy if intraoperatively the cystic stump can be identified and opened * Ability of subject to understand character and individual consequences of the clinical Trial * Informed consent documented by signature Exclusion Criteria: * Previous cholecystectomy if intraoperative it is not possible to identify the cystic stump * Intraoperative hepatico-jejunostomy * Hypersensitivity to fish-, egg-, soybean or peanut protein or to any of the active ingredients or excipients * Immunosuppression, pregnancy * Emergency liver resection because of traumatic liver rupture * Enrolment of the investigator, his/her family members, employees and other dependent persons
💊

What it tests

  • "white" test" (= the administration of SMOFlipid retrograde through the cystic duct)
📍

Where

5 sites
Department of Visceral Surgery, Cantonal Hospital of Aarau
Aarau, Switzerland
Clarunis Basel, Universitäres Bauchzentrum Basel
Basel, Switzerland
Kantonsspital Luzern
Lucerne, Switzerland
Ospedale Regionale di Lugano
Lugano, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy